Contrast-induced nephropathy after Iomeron-400 or Iodixanol-320 in patients with moderate-to-severe chronic kidney disease: the ACTIVE study

被引：0
|
作者：
Thomsen, H. K. [1 ]
Morcos, S. K. [2 ]
Erley, C. M. [3 ]
Grazioli, L. [4 ]
Bonomo, L. [5 ]
Xu, J. -R. [6 ]
Romano, L. [7 ]
机构：
[1] Copenhagen Univ Hosp, Herlev, Denmark
[2] Univ Sheffield, Sheffield, S Yorkshire, England
[3] St Joseph Hosp, Berlin, Germany
[4] Univ Brescia Hosp, Brescia, Italy
[5] Policlin Gemelli, Rome, Italy
[6] Rem Ji Hosp, Shanghai, Peoples R China
[7] AORN Antonio Cardarelli, Naples, Italy
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：626 / 627
页数：2
相关论文
共 50 条
  • [1] The ACTIVE trial: Comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography
    Erley, C. M.
    Henrik S, H. S.
    Morcos, S. K.
    Grazioli, L.
    Ni, Z.
    Romano, L.
    CIRCULATION, 2008, 118 (12) : E430 - E430
  • [2] Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease
    Kroneberger, Christian
    Enzweiler, Christian N.
    Schmidt-Lucke, Andre
    Rueckert, Ralph-Ingo
    Teichgraeber, Ulf
    Franiel, Tobias
    ACTA RADIOLOGICA OPEN, 2015, 4 (06)
  • [3] Contrast-induced nephropathy after a second percutaneous coronary intervention in patients with chronic kidney disease
    覃雪清
    谭宁
    甘富东
    周颖玲
    陈纪言
    杨大浩
    South China Journal of Cardiology, 2011, 12 (04) : 227 - 240
  • [4] Renal outcome of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease
    Nomura, Seitaro
    Taki, Fumika
    Tamagaki, Keiichi
    Futatsuyama, Miyuki
    Nishihara, Shuhzo
    Anzai, Hitoshi
    Nishi, Yutaro
    Takao, Nobuhiro
    Hayashida, Noriaki
    Komatsu, Yasuhiro
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 146 (02) : 295 - 296
  • [5] Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography - A double-blind comparison of iodixanol and iopamidol
    Barrett, Brendan J.
    Katzberg, Richard W.
    Thomsen, Henrik S.
    Chen, Nan
    Sahani, Dushyant
    Soulez, Gilles
    Heiken, Jay P.
    Lepanto, Luigi
    Ni, Zhou-Hui
    Nelson, Rendon
    INVESTIGATIVE RADIOLOGY, 2006, 41 (11) : 815 - 821
  • [6] Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease
    Toprak, O
    Cirit, M
    Esi, E
    Postaci, N
    Yesil, M
    Bayata, S
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 67 (02) : 227 - 235
  • [7] Economical benefit of the prevention of contrast-induced nephropathy in patients with chronic kidney disease
    Takano, H.
    Yamamoto, E.
    Takano, M.
    Takagi, G.
    Asai, K.
    Yasutake, M.
    Mizuno, K.
    EUROPEAN HEART JOURNAL, 2009, 30 : 238 - 238
  • [8] Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease
    Jordan L. Rosenstock
    Emmanuelle Gilles
    Ari B. Geller
    Georgia Panagopoulos
    Staicy Mathew
    Deepa Malieckal
    Maria V. DeVita
    Michael F. Michelis
    International Urology and Nephrology, 2010, 42 : 1049 - 1054
  • [9] Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease
    Rosenstock, Jordan L.
    Gilles, Emmanuelle
    Geller, Ari B.
    Panagopoulos, Georgia
    Mathew, Staicy
    Malieckal, Deepa
    DeVita, Maria V.
    Michelis, Michael F.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (04) : 1049 - 1054
  • [10] Is contrast medium dose a risk factor for the development of contrast-induced nephropathy in patients with chronic kidney disease?
    Kim, Byoung-Keuk
    Oh, Sungjin
    Choi, Daesik
    Kim, Kyung Heui
    Jeon, Deng Woon
    Yang, Joe Young
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 16B - 16B
12345